171 related articles for article (PubMed ID: 10225829)
1. Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Makino M; Azuma M; Wakamatsu SI; Suruga Y; Izumo S; Yokoyama MM; Baba M
Clin Diagn Lab Immunol; 1999 May; 6(3):316-22. PubMed ID: 10225829
[TBL] [Abstract][Full Text] [Related]
2. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis.
Makino M; Shimokubo S; Wakamatsu SI; Izumo S; Baba M
J Virol; 1999 Jun; 73(6):4575-81. PubMed ID: 10233916
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
4. An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.
Manuel SL; Sehgal M; Khan ZK; Goedert JJ; Betts MR; Jain P
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1273-85. PubMed ID: 23750452
[TBL] [Abstract][Full Text] [Related]
5. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
Azimi N; Jacobson S; Leist T; Waldmann TA
J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
[TBL] [Abstract][Full Text] [Related]
6. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones.
Wucherpfennig KW; Höllsberg P; Richardson JH; Benjamin D; Hafler DA
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2110-4. PubMed ID: 1549569
[TBL] [Abstract][Full Text] [Related]
7. CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Menezes SM; Decanine D; Brassat D; Khouri R; Schnitman SV; Kruschewsky R; López G; Alvarez C; Talledo M; Gotuzzo E; Vandamme AM; Galvão-Castro B; Liblau R; Weyenbergh JV
J Neuroinflammation; 2014 Jan; 11():18. PubMed ID: 24472094
[TBL] [Abstract][Full Text] [Related]
8. Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease.
Enose-Akahata Y; Matsuura E; Tanaka Y; Oh U; Jacobson S
Retrovirology; 2012 Feb; 9():16. PubMed ID: 22335964
[TBL] [Abstract][Full Text] [Related]
9. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation.
Macatonia SE; Cruickshank JK; Rudge P; Knight SC
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1699-706. PubMed ID: 1457215
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
Goncalves DU; Proietti FA; Barbosa-Stancioli EF; Martins ML; Ribas JG; Martins-Filho OA; Teixeira-Carvalho A; Peruhype-Magalhães V; Carneiro-Proietti AB
Inflamm Allergy Drug Targets; 2008 Jun; 7(2):98-107. PubMed ID: 18691139
[TBL] [Abstract][Full Text] [Related]
12. Decrease in naïve T cell production due to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development.
Gomes JAN; da Silva Dias GA; Fujihara S; Yoshikawa GT; Koyama RVL; Sousa RCM; Quaresma JAS; Fuzii HT
Immunobiology; 2021 Jan; 226(1):152050. PubMed ID: 33338979
[TBL] [Abstract][Full Text] [Related]
13. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of TGF-beta 1 on the in vitro activation of HTLV-I and the proliferative response of CD8+ T lymphocytes in patients with HTLV-I-associated myelopathy (HAM/TSP).
Nagai M; Ijichi S; Hall WW; Osame M
Clin Immunol Immunopathol; 1995 Dec; 77(3):324-31. PubMed ID: 7586743
[TBL] [Abstract][Full Text] [Related]
15. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
16. [HTLV-I--associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Makino M
Ryoikibetsu Shokogun Shirizu; 2000; (31):9-12. PubMed ID: 11269197
[No Abstract] [Full Text] [Related]
17. Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
Rizkallah G; Alais S; Futsch N; Tanaka Y; Journo C; Mahieux R; Dutartre H
PLoS Pathog; 2017 Apr; 13(4):e1006353. PubMed ID: 28426803
[TBL] [Abstract][Full Text] [Related]
18. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
19. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation.
Mostoller K; Norbury CC; Jain P; Wigdahl B
J Neurovirol; 2004 Dec; 10(6):358-71. PubMed ID: 15765807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
